Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9098556 | 0.92 | PTGS2 (0.38) | PTGS2PTGS1TP53ITGB1ITGA4 | |
| SCHEMBL8551146 | 0.89 | PTGS2 (0.40) | PTGS2PTGS1TP53 | |
| SCHEMBL8548972 | 0.85 | PTGS2 (0.42) | PTGS2PTGS1TP53 | |
| SCHEMBL8548704 | 0.84 | PTGS2 (0.43) | PTGS2PTGS1TP53 | |
| SCHEMBL8551014 | 0.84 | PTGS2 (0.41) | PTGS2PTGS1TP53ITGB1ITGA4 | |
| SCHEMBL8551018 | 0.84 | PTGS2 (0.41) | PTGS2PTGS1TP53 | |
| SCHEMBL8546636 | 0.82 | PTGS2 (0.40) | PTGS2PTGS1TP53 | |
| SCHEMBL8551144 | 0.82 | ERN1 (0.42) | PTGS2PTGS1TP53 | |
| SCHEMBL8551355 | 0.80 | PTGS2 (0.50) | PTGS2PTGS1 | |
| SCHEMBL8551034 | 0.77 | PTGS2 (0.42) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0825989-A1 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-03-04 | — | — | EP | disclosed |